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INTRODUCTION
Malaria is the second commonest infectious disease
with a high mortality globally, with the greatest burden
of morbidity and mortality in sub-Saharan Africa. This
represents over 90% of  global deaths.1 Although, there
is a general risk for malaria within the population, there
is an increased vulnerability of some population groups
to this disease. In Sub-Saharan Africa, high risk
population groups include pregnant women, infants,
children less than five years of age, patients with HIV/
AIDS, non-immune migrants, mobile populations as
well as travelers.2 Malaria in pregnancy (MiP) has
remained a major public health issue with documented
adverse effects on both mother and child. Maternal
consequences of MiP include high blood parasitaemia
and maternal anemia while consequences to the child
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includes miscarriages and low birth weight (LBW)
which is further compounded by attendant sequel of
sickness and death in infancy through the mechanism
of Intrauterine Growth Restriction (IUGR) and
preterm delivery.3,4
Intermittent preventive treatment of  malaria in
pregnancy using Sulphadoxine- pyrimethamine (IPTp-
SP) was one of  three interventions designed by World
Health Organization (WHO) to control MiP especially
in malaria endemic regions where pregnant women
are required to receive at least two doses of IPTp
after quickening till birth. This is based on the
assumption that every pregnant woman living in malaria
endemic area with or without symptoms of malaria
ABSTRACT
Background: Malaria is of  global health concern particularly among pregnant
women. Nigeria contributes largely to global burden but coverage of
Intermittent Preventive Treatment of  malaria in pregnancy using
Sulphadoxine pyrimethamine remains low. This study was conducted to
determine the national situation of  missed opportunity for IPTp-SP and
attempted to look at correlates and predictors.
Method: The study used secondary data analysis of  the Nigeria Demographic
Health Survey, 2013. Data on socio-demographics, ANC characteristics and
IPTp-SP use during pregnancy among 6,910 women aged 15-49 years who
delivered in the last two years with at least 4 ANC visits were analyzed. Missed
opportunity for IPTp delivery was defined as an ANC visit where IPTp was
not delivered as per the policy. Data was analyzed using SPSS version 21.
Associations used Chi-square test and significant variables were fit into multi-
variate logistic regression model. All analyses were performed at 5% level of
significance.
Results: National prevalence for missed opportunity for IPTp-SP was high
(73.4%). Predictors of missed opportunity are being of poorer, middle and
richer wealth index (OR=0.737, CI 0.566-0.960); (OR=0.659, CI 0.521-0.833);
(OR=0.686, CI 0.550-0.857), residence in South East OR=0.549, CI (0.415-0.726)
and in the North West (OR=0.176, CI 0.133-0.232). Other predictors are having
a primary and secondary education and presenting for the first ANC visit in
the second trimester OR=0.739, p=0.024, CI (0.569-0.961).
Conclusion: Missed opportunity for IPTp-SP was high. The need for stronger
governmental commitment to upscale uptake of  IPTp-SP by incorporating
the knowledge of socio-economic, cultural and demographic barriers to
accessing IPTp is paramount.
Keywords: Missed opportunity, Malaria in pregnancy, Nigeria.
Ann Ibd. Pg. Med 2017. Vol.15, No.2 88-95
                                                   Annals of Ibadan Postgraduate Medicine. Vol. 15 No. 2, December 2017 89
has malaria parasites in her blood or placenta, with
increased susceptibility in the second and third trimester
of  pregnancy.3 In 2012, the WHO updated
recommendations for IPTp-SP now stipulated that
commencing from the second trimester; all pregnant
women take Sulphadoxine-pyrimethamine at each
scheduled antenatal care visit (ANC), with doses given
at least one month apart under the supervision of  a
trained health care practitioner. This recommendation
was a sequelae to evidences showing low uptake of
IPTp-SP, believing that the new recommendation will
ensure that a greater proportion of women receive at
least three doses of  SP during each pregnancy.4 In spite
of this modification, IPTp-SP uptake in sub-Saharan
Africa still remains largely sub-optimal.5 This sub-
optimal IPTp-SP uptake within the context of high
ANC attendance represents significant missed
opportunities for IPTp-SP at ANC facilities. 6
Consequently, an ANC visit with non delivery of  IPTp-
SP as per policy is termed a missed opportunity which
is measured in this study as the number of pregnant
women with less than two IPTp-SP uptake despite
four ANC visits.7 Due to the integration of  IPTp-SP
to ANC, this programme’s uptake is also subject to
overwhelming challenges which are influenced by
supply and demand for ANC services, general health
systems weakness as well as socio-economic,
demographic and cultural barriers to accessing
health.9,10,11 Hence, the progress recorded in the battle
against the prevention of the occurrence of malaria in
pregnancy has been much slower compared to that
against malaria in the general population in the last 16
years.8
Evidences have shown that among pregnant women
in Sub- Saharan African countries in 2010, the average
coverage of at least two doses of IPTp was 14%
with a marginal increase in uptake to 24% in 2013.
This was found to be well below global and national
target of  80% coverage for IPTp-SP. In Africa, only
six countries reached the Roll Back Malaria (RBM)
coverage target of 60% in 2006 while none has met
the 2010 target of 80%.6 A 2014 WHO report revealed
that in 2013, of the 35 million pregnant women at risk
for MiP approximately half of them did not receive a
single dose of  IPTp-SP. In the same year, IPTp
adoption was implemented in 35 countries in malaria
endemic African countries, but only 57% of pregnant
women in those countries received at least one dose
of  IPTp. Following the updated WHO recommen-
dation on IPTp-SP use for the prevention of malaria
in pregnancy, only nine of  the 35 countries have
reported to the WHO on the recommended number
of  three or more doses of  IPTp, while 17% of
pregnant women received three or more doses within
those countries.9 This represents a huge gap for missed
opportunities for the prophylaxis of malaria in
pregnancy.
In Nigeria, studies have shown large disparities in
prevalence rates for malaria in pregnancy across
different parts of Nigeria, ranging from 19.7% to
72.0%.10 Documented evidences of uptake of IPTp-
SP in Nigeria typify the African picture. Reports from
the Nigeria Demographic Health Survey 2013 showed
that of  all pregnant women interviewed, only 15%
received IPTp-SP during ANC and less than 10%
received 3 or more doses of  IPTp-SP.11 Findings also
show that uptake of  IPTp-SP in Nigeria is low, while
its level of missed opportunity remains high.12,13 This
observation in addition to evidence of  Nigeria’s huge
contribution to the global burden of malaria
emphasizes the need to assess how well the nation has
performed in terms uptake of  IPTp among pregnant
women nationally. The aim of  this study was to
determine the prevalence and predictors of  missed
opportunity for IPTp among a nationally representative
sample of women who had at least one delivery within
two years of  the study. Findings from this study will
provide information which could assist national
working groups on malaria prevention in pregnancy
to prioritize and implement appropriate strategies
which address the challenges facing the uptake of IPTp-
SP in Nigeria.
METHODS
We carried out a secondary analysis of  data from the
2013 National Demographic and Health Survey
(NDHS);11 a nationally representative population-based
cross-sectional survey involving data collection from
selected locations in the 36 states of  the Federation
and the Federal Capital Territory. Permission to use
the NDHS dataset was obtained from the MEASURE
DHS program.
The study population was randomly selected using a
three step stratified sampling method. Stratification was
achieved by separating each state into urban and rural
areas. Selected localities were used in the first stage,
enumeration areas in the second and a fixed number
of household were selected through equal probability
sampling for the third stage. All women aged 15-49
who were either permanent residents of  the selected
households or visitors who stayed in the households
the night before the survey were eligible to be
interviewed.
The women’s health questionnaire was administered
to women aged 15-49 years where a sample of 37,928
individuals was originally drawn. For the purposes of
this study a total of 6910 women whose most recent
pregnancy resulted in a live birth in the past 2 years
                                                   Annals of Ibadan Postgraduate Medicine. Vol. 15 No. 2, December 2017 90
with more than 4 ANC visit were analyzed.
Respondents were recategorized into proportion
receiving less than or more than two doses of IPTp-
SP. As nearly all surveys were conducted before the
updated WHO policy in 2012 emphasizing dosing of
IPTp-SP at each ANC visit, the proportion receiving
two or more doses of IPTp-SP was used as the
primary comparison in this analysis.
Relevant questions were identified from the women
questionnaire dataset. To ensure that calculated
estimates were independently observed from recent
births, analyses was performed using information on
the most recent pregnancy resulting in a live birth within
the last two years prior to survey date. Data on
pregnancy, ANC attendance and Sulphadoxine
pyrimethamine use were extracted from the survey
and analyzed using SPSS statistical package (version
21). The data was weighted using the women individual
sample weight. The independent variables were derived
from the socio-demographic details of the women
while the dependent variable used for this study was
missed opportunity for IPTp-SP. Missed opportunity
among women whose most recent pregnancy resulted
in a live birth in the past 2 years in percentage was
defined as:
Women aged 15-49 who had a live birth 2 years
preceding the survey and who attended ANC at least
4 times in their last pregnancy and received less than 2
doses of  IPTp.
Total number of  women aged 15-49 who had a live
birth 2 years preceding the survey and who attended
ANC at least 4 times in their last pregnancy.
Bivariate analyses of selected socio-demographic
characteristics were associated with missed opportunity
for IPTp-SP. Statistical significance level was set at P
<0.05. Multivariate logistic regression analysis was
carried out to identify predictors of missed
opportunity for IPTp-SP in the study population.
RESULTS
This study analyzed socio-demographic and health data
of 6,910 women aged 15 to 49 years who gave birth
within two years of  the survey and had made a
minimum of four antenatal care (ANC) visits during
the last pregnancy. Socio-demographic characteristics
are presented in Table 1. The mean age of  the women
was 28.69±0.19 years, with majority 5028 (72.8%) of
the eligible respondents within the age group of 20-
34 years. The Hausa/Fulani tribe comprised about a
quarter, 1753 (25.4%) of the sample of women.  The
highest level of education for 2867 (41.5%) of the
respondents was secondary education. Most of the
respondents 6558 (94.9%) were currently in union or
living with a partner, 1976 (28.6%) were in the richest
wealth quintile and 3614 (52.6%) were Christians. Table
2 shows the proportion of missed opportunity for
the preventive treatment of malaria in pregnancy in
Nigeria (representing the proportion of women who
received less than two doses of IPTp-SP despite a
minimum of  four ANC visits). Observed prevalence
of missed opportunity using the previous WHO
recommendation of at least 2 doses in each pregnancy
was 4984 (73.4%). Higher rates 6103 (88.6%) of missed
opportunity for IPTp-SP was reported using the 2012
updated WHO recommendation for the preventive
treatment of malaria in pregnancy where a minimum
of  three doses of  SP is recommended per pregnancy.
Table 3 presents findings on the association between
selected factors and missed opportunity for IPTp-SP
among the respondents in Nigeria. The highest rates
of missed opportunity for IPTp-SP were reported
among women who have completed secondary
education (78.5%) while the lowest rates (61.6%) were
reported among women with no education (p<0.001).
Variables N=6910 n (%)










Highest level of education
No education 1807 (26.1)
Primary education 1467 (21.2)
Secondary education 2867 (41.5)
Higher/Tertiary education 769 (11.1)
Living status of respondents
Never in union 207(3.0)
Currently in union living with partner 6658 (94.9)













Table 1: Socio-demographic characteristics of the
study respondents
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Using 2 doses as standard for determining missed opportunity for IPTp-SP
Variables N=6910 n (%) 95% Confidence Interval p-value
Yes
Missed opportunities** 4984 (73.4) 71.8,75.0 <0.001*
No missed opportunities 1804 (26.6) 25.0,28.2
Missing data 122
Using 3 doses as standard for determining missed opportunity for IPTp-SP
Missed opportunities 6103 (88.6) 87.5,89.6 <0.001*
No missed opportunities 775 (11.4) 10.4,12.5
Missing data 122
Table 2: Rates of  missed opportunity for the preventive treatment of  malaria in pregnancy in Nigeria in 2013
at IPTp-SP <2 doses
*Statistically significant
** At the time of data collection, the definition of missed opportunity was determined as less than two doses of IPTp-SP despite four or
more ANC visits
Variable N=6910 Missed opportunity 95% Confidence
Interval
x2 p-value
Yes (%) No (%)
Age of respondent (years)
<20 72.4 27.6 66.8,77.3 2.431 0.425
20-34 73.9 26.1 72.2,75.6
>35 72.2 28.0 69.1,74.8
Missing data 122
Highest level of education
No education 61.6 38.4 58.2,64.9 175.250 <0.001*
Primary education 75.9 24.1 73.2,78.4
Secondary education 78.5 21.5 76.4,80.5
Higher/Tertiary education 77.1 22.9 73.1,80.7
Missing data 122
Wealth index
Poorest 69.3 30.7 65.0,73.3 69.670 <0.001*
Poorer 68.9 31.1 65.0,72.5
Middle 70.8 29.2 67.3,74.0
Richer 72.2 27.8 69.0,75.2
Richest 80.2 19.8 77.6,82.6
Missing data 122
Religion
Christian 81.7 18.3 79.9,83.4 264.863 <0.001*
Islam 64.3 35.7 61.6,66.8
Traditionalist 83.6 16.4 67.5,92.6
Missing data 165
Type of place of residence N=6910
Urban 76.0 24.0 73.8,78.0 23.571 0.001*
Rural 69.6 29.2 68.4,73.0
Missing data 122
Parity
1-2 76.1 23.9 74.1,78.1 25.662 <0.001*
3-4 73.5 26.5 70.9,76.0
>4 69.6 30.4 66.9,72.2
Missing data 122
Timing of first ANC (months)
<3 75.3 24.7 72.7,77.8 9.939 0.038*
4-6 72.1 27.9 70.2,74.0
>6 76.7 23.3 71.8,81.0
Missing data 144
Type of care provider
No care/care by others 75.2 24.8 70.8,79.1 1.243 0.416
Care by Skilled birth attendant 73.3 26.7 71.5,74.9
Missing data 158
Table 3: Correlates of  missed opportunity for IPTp-SP in Nigeria
*Significant
                                                   Annals of Ibadan Postgraduate Medicine. Vol. 15 No. 2, December 2017 92
Women in the richest cadre of  the wealth index
reported a missed opportunity of 80.2% compared
to 68.9% among women in the poorer wealth quintile
(p<0.001). With respect to religion, rates of missed
opportunities for IPTp-SP ranged from 64.3% among
those practicing Islamic religion to 83.6% among
traditional religion adherents (p<0.001). Age of the
respondents was not significantly associated with
missed opportunity.
It further describes the rates for missed opportunity
for IPTp-SP among respondents in Nigeria by type
of place of residence, pregnancy characteristics and
type of  care provider in pregnancy. Rates of  missed
opportunity for IPTP-SP were higher among
respondents in urban (76.0%) than rural (69.6%) areas
(p=0.001); rates were also highest among women who
reported a parity of one to two (76.1%) compared to
their counterparts who had a parity of four and above
(69.6%) (p<0.001). Approximately 77.0% of women
with timing of their first ANC in the third trimester
reported as missed opportunity for IPTp-SP
compared to 72.1% of women whose first ANC was
in the second trimester (p=0.038). There was no
significant association between type of care-giver
during ANC and missed opportunity.
Variable Adjusted Odds 95% Confidence Interval p-value
Upper Lower
Age of respondents (years)
<20 1.201 0.890 1.621 0.231
20-34 1.087 0.929 1.271 0.297
>35 1
Highest level of education
No education 0.936 0.676 1.296 0.690
Primary education 1.402 1.062 1.851 0.017*
Secondary education 1.344 1.065 1.695 0.013*
Higher/Tertiary education 1
Wealth index
Poorest 0.952 0.697 1.302 0.759
Poorer 0.737 0.566 0.960 0.024*
Middle 0.659 0.521 0.833 0.001*
Richer 0.686 0.550 0.857 0.001*
Richest 1
Religion
Christian 0.768 0.314 1.875 0.562
Islam 0.353 0.147 0.845 0.020*
Traditionalist 1
Type of place of residence
Urban 0.955 0.800 1.139 0.607
Rural 1
Region of residence
North central 0.324 0.239 0.438 <0.001*
North east 0.365 0.281 0.475 <0.001*
North west 0.176 0.133 0.232 <0.001*
South east 0.549 0.415 0.726 <0.001*
South south 0.860 0.630 1.176 0.345
South west 1
Parity
1-2 1.113 0.944 1.312 0.202
3-4 0.964 0.812 1.145 0.676
>4 1
Timing of first Antenatal visit
First trimester 0.756 0.566 1.009 0.058
Second trimester 0.739 0.569 0.961 0.024*
Third trimester 1
Table 4: Predictors of missed opportunity for IPTp-SP among respondent in Nigeria
*Significant
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Tables 4 show the adjusted odds of  missed opportunity
for IPTp-SP for selected socio-demographic
characteristics, location and pregnancy characteristics
of  respondent in Nigeria. Women whose highest levels
of education were primary and secondary levels were
approximately 1.4 times more at risk for missed
opportunity for IPTp-SP than women who had tertiary
level of education (OR= 1.402, CI (1.062-1.851),
p=0.017; OR=1.344, CI (1.065-1.695), p=0.013,
respectively. However, being of  the poorer, middle
and richer quintile confers an approximately 1.5 times
less risk than those of the richest quintile for missed
opportunity OR=0.737, p=0.024, CI (0.566-0.960);
OR=0.659, p=0.001, CI (0.521-0.833); OR=0.686,
p=0.001, CI (0.550-0.857). Muslims were 2.8 times
less likely for missed opportunity when compared to
women who are traditional worshippers OR=0.353,
p=0.020, CI (0.147-0.845).
Another predictor of missed opportunity in Nigeria
was region, where women resident in South East were
1.8 times less likely to have missed opportunity than
women in the South West OR=0.549, p<0.001, CI
(0.415-0.726), while women in the North Central and
North East were twice less likely to report as a missed
opportunity than women in the South West OR=0.324,
p<0.001, CI (0.239-0.438) and OR=0.365, p<0.001,
CI (0.281-0.475) respectively. Being resident in North
West confers approximately 6 times less risk compared
to South West OR=0.176, p<0.001, CI (0.133-0.232).
Timing of first ANC visit in the second trimester
confers a 1.4 times less risk for missed opportunity
compared to women who presented in the third
trimester OR=0.739, p=0.024, CI (0.569-0.961).
DISCUSSION
This study showed that approximately two thirds of
the eligible respondents who had a minimum of
(four) antenatal visits reported as a missed opportunity
for IPTp-SP in Nigeria, which represents a significant
proportion of  missed opportunity. This was
comparable to rates found in a study conducted in
Uganda,5 but much higher than rates reported in Niger,
Senegal and in Malawi.7 Anecdotal evidences show that
the higher rates of missed opportunity for IPTp-SP
observed in Nigeria could be attributed to the poorly-
structured and poorly-financed health care system in
the country. This may have resulted in a poorly
integrated malaria programme with the reproductive
health component of the national health care system
where resources needed for the effective programme
implementation are lacking.13
Analysis using the updated WHO 2012 policy
recommendation of a minimum of three doses of
SP in the preventive treatment of malaria in pregnancy
in this study, reported majority of  the respondents as
missed opportunity. Approximately one third of
women attending >4 ANC visits received either the
first or second dose of IPTp-SP while two thirds
received none at all. A possible reason for this could
be shortage of  the drugs at ANC facilities. As
inadequacy in the supply arm has been cited as a
possible explanation for low effectiveness of IPTp-
SP delivery.14 The observation in the current study
shows that Nigeria has been unable to meet  one of
the targets of the Roll Back Malaria initiative, i.e. of
achieving a 100% coverage for the intermittent
preventive treatment of malaria in pregnancy by 2015.15
This finding calls for increased efforts by the
government to achieve this target. A possible strategy
could be addressing observed cultural and socio-
demographic barriers to uptake of IPTp-SP as well
as providing the necessary logistics to optimize IPTp-
SP within the gambit of ANC. Socio-demographic
factors associated with missed opportunity in Nigeria,
were level of education, wealth index and religion of
respondents. This study showed that educated women
were more at risk for missed opportunity compared
to those with no education which was contrary to the
study by Masaninga et al., where increased uptake of
IPTp-SP was associated with secondary education.
This is likely because educated women are more likely
to have a busier schedule because of work and thus
do not fully maximize all the benefits of the ANC
visit. There is need for health personnel to ensure they
appropriately dispel any misconceptions about the drug
Sulphadoxine pyrimethamine.
This study also showed that women within the richest
quintile and those who are traditional worshippers are
more likely to have missed opportunity compared to
women of other quintiles and Muslim women
respectively. This might have been caused by several
factors which this study did not explore; hence a
qualitative study would probably be able to provide a
better explanation for this observation. Hence,
awareness campaigns at sensitizing the community
about the dangers of malaria in pregnancy as well as
efficacy of SP should integrate strategies that will
impact across educational and socio-economic sub-
grouping.
Determinants of  missed opportunities in this study
showed type of place of residence is associated with
prevalence of missed opportunity which is reportedly
higher in the urban place of residence; this is in contrast
with findings from the study of uptake of IPTp
women in Zambia.16 This might be due to the inequity
of access which may be higher in the urban compared
to the rural type of residence hence the increased
chances for missed opportunity among clients. This
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study also shows that region of residence is also
associated with missed opportunity for IPTp-SP in
similarity to other studies.8,17 The higher odds of  missed
opportunity observed in the South-West may be due
to over-concentration of non-governmental
organizations to support governmental efforts in the
programme planning and implementation in the
Northern part of Nigeria compared to the Southern
part. This may be due to perceived cultural and
religious belief that hinder uptake of hospital based
health interventions in the Northern regions. The ability
to replicate successful programme planning and
implementation to other regions, while allowing
programme flexibility to adapt to local circumstance
is a key way of ensuring successful malaria control
interventions in Nigeria.
With regards to pregnancy characteristics, this study in
similarity with others shows that parity and timing of
first visit of  ANC are determinants of  missed
opportunity8,17,18,19 while this study’s observation
contrast with a study done in Ghana where timing of
first visit of ANC was not associated with missed
opportunity.19 This study further showed that
presenting in the second trimester reduced the risk of
missed opportunity for IPTp-SP 1.4 times compared
to women who presented for ANC visit for the first
time in the third trimester. This may be due to the fact
that early presentation for ANC optimizes the chances
that pregnant mothers will take the standard doses of
SP as per policy. This is even more important in the
face of up-scaling national uptake of SP to the
standard 3 doses or more as recommended by the
updated WHO recommendation for the preventive
treatment of  malaria in pregnancy.20
CONCLUSION
Despite a decade post implementation of  IPTp-SP,
the abysmally low uptake evidenced by the magnitude
of  missed opportunity for this intervention necessitates
a strategic approach to upscale the uptake of IPTp-
SP in line with global agenda.6 This can only be a reality
with a stronger governmental commitment to
strengthen national health systems as well as position
them to optimally deliver integrated programmes that
factor social, demographic and cultural barriers to
uptake of  IPTp-SP.
LIMITATION
A limitation in this study was the fact that it was a
secondary data analysis, hence authors had no control
on the variables investigated. Other factors such as
knowledge of malaria in pregnancy and IPTp-Sp
among respondents as well as supply side factors such
as health worker knowledge and attitude, presence or
absence of SP could not be assessed. It is important
to state that this study was based on a nationally
representative and large sample. It is believed that
despite these limitations the study findings contributes
significantly to existing knowledge and have strong
policy impact.
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